Skip to main content
Top
Published in: European Journal of Medical Research 1/2020

Open Access 01-12-2020 | Imipenem | Research

The stability of carbapenems before and after admixture to PMMA-cement used for replacement surgery caused by Gram-negative bacteria

Authors: Matthias Schmid, Oliver Steiner, Lisa Fasshold, Walter Goessler, Anna-Maria Holl, Klaus-Dieter Kühn

Published in: European Journal of Medical Research | Issue 1/2020

Login to get access

Abstract

Background

Prosthetic joint infection (PJI) is a serious complication of orthopedic implant surgery. Treatment often includes the use of an antibiotic-loaded Polymethyl methacrylate (PMMA) bone cement spacer. Several antibiotics are commonly used for the preparation of these spacers, but due to the increasing number of infections with resistant Gram-negative bacteria, there is a need for the use of carbapenem antibiotics such as meropenem and imipenem as drugs of last resort. Unfortunately, the reaction heat generated during the preparation of the bone cement can be a major problem for the stability of these antibiotics. In the present study, the stability of meropenem and imipenem was tested before and after the admixture to PMMA bone cements.

Methods

High-performance liquid chromatography with ion-pairing reversed-phase separation and spectrophotometric detection was used for analysis. Stability tests with meropenem and imipenem were performed with antibiotics in solution and solid form at different temperatures (37 °C, 45 °C, 60 °C, 90 °C) and times (30 min, 60 min, 120 min). To test the stability of both antibiotics in PMMA after exposure to the reaction heat during polymerization, three different bone cements were used to generate specimens that contained defined amounts of antibiotics. Reaction heat was measured. The form bodies were mechanically crushed and aliquots were dissolved in ethyl acetate. Samples were prepared for HPLC DAD analysis.

Results

Meropenem and imipenem showed the highest degradation levels after heat stressed in solution, with maximum levels of 75% and 95%, respectively. In solid form, degradation levels decreased dramatically for meropenem (5%) and imipenem (13%). Stability tests of both carbapenems in bone cement showed that they remained largely stable during PMMA polymerization, with retrieved amounts of about 70% in Palacos® R and Copal® G+V, and between 80 and 90% in Copal® spacem.

Conclusions

In contrast to the results of meropenem and imipenem in solution, both antibiotics remain stable in solid form and mostly stable in the cement after PMMA polymerization. The low degradation levels of both antibiotics after exposure to temperatures > 100 °C allow the conclusion that they can potentially be used for an application in PMMA cements.
Literature
1.
go back to reference Wengler A, Nimptsch U, Mansky T. Hip and knee replacement in Germany and the USA—analysis of individual inpatient data from German and US hospitals for the years 2005 to 2011. Dtsch Arztebl Int. 2014;111(23–24):407–16.PubMedPubMedCentral Wengler A, Nimptsch U, Mansky T. Hip and knee replacement in Germany and the USA—analysis of individual inpatient data from German and US hospitals for the years 2005 to 2011. Dtsch Arztebl Int. 2014;111(23–24):407–16.PubMedPubMedCentral
2.
go back to reference Kurtz SM, Ong KL, Lau E, Widmer M, Maravic M, Gómez-Barrena E, et al. International survey of primary and revision total knee replacement. Int Orthop. 2011;35(12):1783–9.PubMedPubMedCentralCrossRef Kurtz SM, Ong KL, Lau E, Widmer M, Maravic M, Gómez-Barrena E, et al. International survey of primary and revision total knee replacement. Int Orthop. 2011;35(12):1783–9.PubMedPubMedCentralCrossRef
3.
go back to reference Jacqueline C, Caillon J. Impact of bacterial biofilm on the treatment of prosthetic joint infections. J Antimicrob Chemother. 2014;69(Suppl 1):37–40.CrossRef Jacqueline C, Caillon J. Impact of bacterial biofilm on the treatment of prosthetic joint infections. J Antimicrob Chemother. 2014;69(Suppl 1):37–40.CrossRef
5.
go back to reference Zimmerli W, Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158–68.PubMedCrossRef Zimmerli W, Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158–68.PubMedCrossRef
6.
go back to reference Maurer TB, Ochsner PE. Infected knee arthroplasty A treatment algorithm at the Kantonsspital Liestal, Switzerland. Orthopade. 2006;35(9):917–8.PubMedCrossRef Maurer TB, Ochsner PE. Infected knee arthroplasty A treatment algorithm at the Kantonsspital Liestal, Switzerland. Orthopade. 2006;35(9):917–8.PubMedCrossRef
8.
go back to reference Harrasser N, Liska F, Gradl G, von Eisenhart-Rothe R. Periprosthetic joint infection: diagnosis and treatment. MMW Fortschr Med. 2011;153(44):43–5.PubMedCrossRef Harrasser N, Liska F, Gradl G, von Eisenhart-Rothe R. Periprosthetic joint infection: diagnosis and treatment. MMW Fortschr Med. 2011;153(44):43–5.PubMedCrossRef
9.
go back to reference Tan TL, Kheir MM, Tan DD, Parvizi J. Polymicrobial periprosthetic joint infections: outcome of treatment and identification of risk factors. J Bone Jt Surg Am. 2016;98(24):2082–8.CrossRef Tan TL, Kheir MM, Tan DD, Parvizi J. Polymicrobial periprosthetic joint infections: outcome of treatment and identification of risk factors. J Bone Jt Surg Am. 2016;98(24):2082–8.CrossRef
10.
go back to reference Senthi S, Munro JT, Pitto RP. Infection in total hip replacement: meta-analysis. Int Orthop. 2011;35(2):253–60.PubMedCrossRef Senthi S, Munro JT, Pitto RP. Infection in total hip replacement: meta-analysis. Int Orthop. 2011;35(2):253–60.PubMedCrossRef
12.
go back to reference Kühn KD, Renz N, Trampuz A. Local antibiotic therapy. Unfallchirurg. 2017;561–72. Kühn KD, Renz N, Trampuz A. Local antibiotic therapy. Unfallchirurg. 2017;561–72.
13.
14.
go back to reference Mendez A, Chagastelles P, Palma E, Nardi N, Schapoval E. Thermal and alkaline stability of meropenem: degradation products and cytotoxicity. Int J Pharm. 2008;350(1–2):95–102.PubMedCrossRef Mendez A, Chagastelles P, Palma E, Nardi N, Schapoval E. Thermal and alkaline stability of meropenem: degradation products and cytotoxicity. Int J Pharm. 2008;350(1–2):95–102.PubMedCrossRef
15.
go back to reference Breilh D, Texier-Maugein J, Allaouchiche B, Saux M-C, Boselli E. Carbapenems. J Chemother. 2013;25(1):1–17.PubMedCrossRef Breilh D, Texier-Maugein J, Allaouchiche B, Saux M-C, Boselli E. Carbapenems. J Chemother. 2013;25(1):1–17.PubMedCrossRef
16.
go back to reference Chowdhury C, Nayak TR, Young KD, Ghosh AS. A weak dd-carboxypeptidase activity explains the inability of PBP 6 to substitute for PBP 5 in maintaining normal cell shape in Escherichia coli. FEMS Microbiol Lett. 2010;303(1):76–83.PubMedCrossRef Chowdhury C, Nayak TR, Young KD, Ghosh AS. A weak dd-carboxypeptidase activity explains the inability of PBP 6 to substitute for PBP 5 in maintaining normal cell shape in Escherichia coli. FEMS Microbiol Lett. 2010;303(1):76–83.PubMedCrossRef
17.
go back to reference Zhanel GG, Simor AE, Vercaigne L, Mandell L, Canadian Carbapenem Discussion Group. Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis. 1998;9(4):215–28.PubMedPubMedCentralCrossRef Zhanel GG, Simor AE, Vercaigne L, Mandell L, Canadian Carbapenem Discussion Group. Imipenem and meropenem: Comparison of in vitro activity, pharmacokinetics, clinical trials and adverse effects. Can J Infect Dis. 1998;9(4):215–28.PubMedPubMedCentralCrossRef
18.
go back to reference Hsieh P, Lee MS, Hsu K, Chang Y, Shih H, Ueng SW. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis. 2009;49(7):1036–43.PubMedCrossRef Hsieh P, Lee MS, Hsu K, Chang Y, Shih H, Ueng SW. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis. 2009;49(7):1036–43.PubMedCrossRef
19.
go back to reference Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA. Comparative review of the carbapenems. Drugs. 2007;67(7):1027–52.PubMedCrossRef Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA. Comparative review of the carbapenems. Drugs. 2007;67(7):1027–52.PubMedCrossRef
21.
go back to reference Traub WH, Leonhard B. Heat stability of the anti-microbial activity of sixty-two antibacterial agents. J Antimicrob Chemother. 1995;35:149–54.PubMedCrossRef Traub WH, Leonhard B. Heat stability of the anti-microbial activity of sixty-two antibacterial agents. J Antimicrob Chemother. 1995;35:149–54.PubMedCrossRef
22.
go back to reference Samara E, Moriarty TF, Decosterd LA, Richards RG, Gautier E, Wahl P. Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cement. Bone Joint Res. 2017;6(5):296–306.PubMedPubMedCentralCrossRef Samara E, Moriarty TF, Decosterd LA, Richards RG, Gautier E, Wahl P. Antibiotic stability over six weeks in aqueous solution at body temperature with and without heat treatment that mimics the curing of bone cement. Bone Joint Res. 2017;6(5):296–306.PubMedPubMedCentralCrossRef
23.
go back to reference Báez LA, Langston C, Givaruangsawat S, McLaughlin R. Evaluation of in vitro serial antibiotic elution from meropenem-impregnated polymethylmethacrylate beads after ethylene oxide gas and autoclave sterilization. Vet Comp Orthop Traumatol. 2011;24(1):39–44.PubMedCrossRef Báez LA, Langston C, Givaruangsawat S, McLaughlin R. Evaluation of in vitro serial antibiotic elution from meropenem-impregnated polymethylmethacrylate beads after ethylene oxide gas and autoclave sterilization. Vet Comp Orthop Traumatol. 2011;24(1):39–44.PubMedCrossRef
24.
go back to reference Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty. 2008;23(8):1232–8.PubMedCrossRef Baleani M, Persson C, Zolezzi C, Andollina A, Borrelli AM, Tigani D. Biological and biomechanical effects of vancomycin and meropenem in acrylic bone cement. J Arthroplasty. 2008;23(8):1232–8.PubMedCrossRef
25.
go back to reference Solomon AW, Stott PM, Duffy K, Kumar PG, Holliman RE, Bridle SH. Elution and antibacterial activity of meropenem from implanted acrylic bone cement. J Antimicrob Chemother. 2010;65(8):1834–5.PubMedCrossRef Solomon AW, Stott PM, Duffy K, Kumar PG, Holliman RE, Bridle SH. Elution and antibacterial activity of meropenem from implanted acrylic bone cement. J Antimicrob Chemother. 2010;65(8):1834–5.PubMedCrossRef
26.
go back to reference Kühn KD. Management of periprosthetic joint infection. 1rst ed. Berlin: Springer-Verlag; 2018.CrossRef Kühn KD. Management of periprosthetic joint infection. 1rst ed. Berlin: Springer-Verlag; 2018.CrossRef
27.
go back to reference Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, et al. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty. 2002;17(5):619–26.PubMedCrossRef Cerretani D, Giorgi G, Fornara P, Bocchi L, Neri L, Ceffa R, et al. The in vitro elution characteristics of vancomycin combined with imipenem-cilastatin in acrylic bone-cements: a pharmacokinetic study. J Arthroplasty. 2002;17(5):619–26.PubMedCrossRef
28.
go back to reference Ensing GT, van Horn JR, van der Mei HC, Busscher HJ, Neut D. Copal® Bone Cement Is More Effective in Preventing Biofilm Formation than Palacos® R-G. Clin Orthop Relat Res. 2008;466(6):1492–8.PubMedPubMedCentralCrossRef Ensing GT, van Horn JR, van der Mei HC, Busscher HJ, Neut D. Copal® Bone Cement Is More Effective in Preventing Biofilm Formation than Palacos® R-G. Clin Orthop Relat Res. 2008;466(6):1492–8.PubMedPubMedCentralCrossRef
Metadata
Title
The stability of carbapenems before and after admixture to PMMA-cement used for replacement surgery caused by Gram-negative bacteria
Authors
Matthias Schmid
Oliver Steiner
Lisa Fasshold
Walter Goessler
Anna-Maria Holl
Klaus-Dieter Kühn
Publication date
01-12-2020
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2020
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-020-00428-z

Other articles of this Issue 1/2020

European Journal of Medical Research 1/2020 Go to the issue